Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth A Jacobson

Showing results (461-470 of 599) with videos related to

Pageof 60
Sort By:
Bioconjugate Chemistry|June 23, 2010
Functionalized congeners of P2Y1 receptor antagonists: 2-alkynyl (N)-methanocarba 2'-deoxyadenosine 3',5'-bisphosphate analogues and conjugation to a polyamidoamine (PAMAM) dendrimer carrierSonia de Castro, Hiroshi Maruoka, Kunlun Hong, et al.
Bioorganic & Medicinal Chemistry|September 10, 2010
Design, synthesis, and binding of homologated truncated 4'-thioadenosine derivatives at the human A3 adenosine receptorsHyuk Woo Lee, Hea Ok Kim, Won Jun Choi, et al.
Journal of Medicinal Chemistry|March 21, 2017
Scaffold Repurposing of Nucleosides (Adenosine Receptor Agonists): Enhanced Activity at the Human Dopamine and Norepinephrine Sodium SymportersDilip K Tosh, Aaron Janowsky, Amy J Eshleman, et al.
Medchemcomm|December 21, 2018
Structure activity relationship of 2-arylalkynyl-adenine derivatives as human A<sub>3</sub> adenosine receptor antagonistsJinha Yu, Philip Mannes, Young-Hwan Jung, et al.
Medchemcomm|July 11, 2015
4-Alkyloxyimino-cytosine nucleotides: tethering approaches to molecular probes for the P2Y<sub>6</sub> receptorP Suresh Jayasekara, Matthew O Barrett, Christopher B Ball, et al.
Journal of Medicinal Chemistry|November 11, 2022
Structure-Activity Studies of 1<i>H</i>-Imidazo[4,5-<i>c</i>]quinolin-4-amine Derivatives as A<sub>3</sub> Adenosine Receptor Positive Allosteric ModulatorsLucas B Fallot, R Rama Suresh, Courtney L Fisher, et al.
ACS Pharmacology & Translational Science|September 14, 2023
First Potent Macrocyclic A<sub>3</sub> Adenosine Receptor Agonists Reveal G-Protein and β-Arrestin2 Signaling PreferencesDilip K Tosh, Courtney L Fisher, Veronica Salmaso, et al.
Structure (London, England : 1993)|February 4, 2018
Structural Connection between Activation Microswitch and Allosteric Sodium Site in GPCR SignalingKate L White, Matthew T Eddy, Zhan-Guo Gao, et al.
Journal of Medicinal Chemistry|October 31, 2003
2-Substitution of adenine nucleotide analogues containing a bicyclo[3.1.0]hexane ring system locked in a northern conformation: enhanced potency as P2Y1 receptor antagonistsHak Sung Kim, Michihiro Ohno, Bin Xu, et al.
Journal of Medicinal Chemistry|June 15, 2007
P2Y1 antagonists: combining receptor-based modeling and QSAR for a quantitative prediction of the biological activity based on consensus scoringStefano Costanzi, Irina G Tikhonova, Michihiro Ohno, et al.
Pageof 60

Showing results (461-470 of 599) with videos related to

Sort By:
Pageof 60
Bioconjugate Chemistry|June 23, 2010
Functionalized congeners of P2Y1 receptor antagonists: 2-alkynyl (N)-methanocarba 2'-deoxyadenosine 3',5'-bisphosphate analogues and conjugation to a polyamidoamine (PAMAM) dendrimer carrierSonia de Castro, Hiroshi Maruoka, Kunlun Hong, et al.
Bioorganic & Medicinal Chemistry|September 10, 2010
Design, synthesis, and binding of homologated truncated 4'-thioadenosine derivatives at the human A3 adenosine receptorsHyuk Woo Lee, Hea Ok Kim, Won Jun Choi, et al.
Journal of Medicinal Chemistry|March 21, 2017
Scaffold Repurposing of Nucleosides (Adenosine Receptor Agonists): Enhanced Activity at the Human Dopamine and Norepinephrine Sodium SymportersDilip K Tosh, Aaron Janowsky, Amy J Eshleman, et al.
Medchemcomm|December 21, 2018
Structure activity relationship of 2-arylalkynyl-adenine derivatives as human A<sub>3</sub> adenosine receptor antagonistsJinha Yu, Philip Mannes, Young-Hwan Jung, et al.
Medchemcomm|July 11, 2015
4-Alkyloxyimino-cytosine nucleotides: tethering approaches to molecular probes for the P2Y<sub>6</sub> receptorP Suresh Jayasekara, Matthew O Barrett, Christopher B Ball, et al.
Journal of Medicinal Chemistry|November 11, 2022
Structure-Activity Studies of 1<i>H</i>-Imidazo[4,5-<i>c</i>]quinolin-4-amine Derivatives as A<sub>3</sub> Adenosine Receptor Positive Allosteric ModulatorsLucas B Fallot, R Rama Suresh, Courtney L Fisher, et al.
ACS Pharmacology & Translational Science|September 14, 2023
First Potent Macrocyclic A<sub>3</sub> Adenosine Receptor Agonists Reveal G-Protein and β-Arrestin2 Signaling PreferencesDilip K Tosh, Courtney L Fisher, Veronica Salmaso, et al.
Structure (London, England : 1993)|February 4, 2018
Structural Connection between Activation Microswitch and Allosteric Sodium Site in GPCR SignalingKate L White, Matthew T Eddy, Zhan-Guo Gao, et al.
Journal of Medicinal Chemistry|October 31, 2003
2-Substitution of adenine nucleotide analogues containing a bicyclo[3.1.0]hexane ring system locked in a northern conformation: enhanced potency as P2Y1 receptor antagonistsHak Sung Kim, Michihiro Ohno, Bin Xu, et al.
Journal of Medicinal Chemistry|June 15, 2007
P2Y1 antagonists: combining receptor-based modeling and QSAR for a quantitative prediction of the biological activity based on consensus scoringStefano Costanzi, Irina G Tikhonova, Michihiro Ohno, et al.
Pageof 60